Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).
Opinion
The New Times on MSN4 小时Opinion
Equity for all: Championing disability inclusion in healthcare
Over time, disability has become a structural factor influencing the quality of life, access to opportunities and health outcomes of those who are affected. According to the World Health Organization ...
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Giverny Capital Asset Management, LLC, an investment management company, recently published its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Bill Gates warns about the rapid advancements and implications of AI on sectors like education and healthcare, stressing the ...
Auxilium 3D prints medical devices onboard the ISS. The AMP-1 bioprinting system remains on the ISS to print implants.
Hill & Ioppolo Oral & Dental Implant Surgery of Lubbock hosted a career event Thursday, to help students looking to be future ...
The pandemic expansion of Medicare telehealth will expire March 31 unless Congress acts to extend Medicare telehealth expansion.
The unique structure of PAMs has the potential to transform industries, from healthcare to robotics, by offering properties never before seen in materials science. PAMs represent a bold step forward ...
The strides we've made in this field inspire hope for a future where hearing loss is not a barrier but a challenge we can ...
Montgomery County's Globus Medical has agreed to acquire a California life sciences company focused on treating chronic pain ...
OpenAI announced this week its AI research assistant, which it calls “ deep research .” Powered by OpenAI’s o3-mini model ...